Inactive Instrument

Press Releases PCI Biotech Oslo Bors

Equities

PCI Biotech Holding ASA - Annual Report 2023	Apr. 26	GL
PCI Biotech second half 2023 interim results	Feb. 14	GL
PCI Biotech second half 2023 interim results	Feb. 14	AQ
PCI Biotech: Invitation to second half interim 2023 results presentation	Feb. 12	GL
PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing	23-10-13	GL
PCI Biotech: European patent for mRNA delivery with fimaNAc	23-09-07	GL
PCI Biotech: Employee share option scheme	23-09-04	GL
PCI Biotech: Employee share option scheme	23-09-04	AQ
PCI Biotech: Write-down of share capital registered	23-09-01	GL
Financial calendar	23-08-31	AQ
PCI Biotech first half 2023 interim results	23-08-31	GL
PCI Biotech: Invitation to first half interim 2023 results presentation	23-08-25	GL
Minutes from Annual General Meeting 2023	23-05-25	GL
PCI Biotech : Q1 2023	23-05-12	PU
PCI Biotech interim Q1 2023 results	23-05-12	GL
PCI Biotech interim Q1 2023 results	23-05-12	AQ
PCI Biotech: Invitation to Q1 2023 results presentation	23-05-09	GL
PCI Biotech : Proposed resolutions for the AGM 2023	23-05-04	PU
PCI Biotech : Remuneration Report 2022	23-05-04	PU
PCI Biotech - Notice of Annual General Meeting 2023	23-05-04	GL

No results for this search